Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
Kazia Therapeutics Shares Drop After FDA Derails Fast Track of Potential Brain Cancer Drug
Kazia Therapeutics股票下跌，因FDA阻礙潛在腦癌藥物的快速通道。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間